Panacea Biotec Intrinsic Value
PANACEABIO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹868.88 | ₹781.99 - ₹955.77 | +150.0% | Book Value/Share: ₹1385.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹695.10 | ₹625.59 - ₹764.61 | +100.0% | Revenue/Share: ₹1000.00, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹139.02 | ₹111.22 - ₹166.82 | -60.0% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check PANACEABIO share price latest .
Valuation Comparison Chart
PANACEABIO Intrinsic Value Analysis
What is the intrinsic value of PANACEABIO?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Panacea Biotec (PANACEABIO) is ₹695.10 (median value). With the current market price of ₹347.55, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹139.02 to ₹868.88, indicating ₹139.02 - ₹868.88.
Is PANACEABIO undervalued or overvalued?
Based on our multi-method analysis, Panacea Biotec (PANACEABIO) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.92 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -13.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.47x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Panacea Biotec
Additional stock information and data for PANACEABIO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-27 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-423 Cr | ₹-423 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-108 Cr | ₹-108 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹107 Cr | ₹83 Cr | Positive Free Cash Flow | 8/10 |